GSDME and neoplasm: Notably, GSDME protein levels in tumor cells increased upon ORFV (MOI = 1) treatment at indicated time points (6 hpi (hours post inoculation) for B16 cell and A549; 12 hpi for 4T1) (Fig. 3f and Supplementary Fig. 6a).